Exosomes in chronic respiratory diseases
Exosomes are nano-sized vesicles released by almost all cell types, with a central role as mediators of intercellular communication. In addition to physiological conditions, these extracellular vesicles seem to play a pivotal role in inflammatory processes. This assumption offers the opportunity to...
Saved in:
Published in | Biomedicine & pharmacotherapy Vol. 144; p. 112270 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
France
Elsevier Masson SAS
01.12.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Exosomes are nano-sized vesicles released by almost all cell types, with a central role as mediators of intercellular communication. In addition to physiological conditions, these extracellular vesicles seem to play a pivotal role in inflammatory processes. This assumption offers the opportunity to study exosomes as promising biomarkers and therapeutic tools for chronic respiratory disorders. Indeed, although it is well-known that at the basis of conditions like asthma, chronic obstructive pulmonary disease, alpha-1 antitrypsin deficiency and idiopathic pulmonary fibrosis there is a dysregulated inflammatory process, an unequivocal correlation between different phenotypes and their pathophysiological mechanisms has not been established yet. In this review, we report and discuss some of the most significant studies on exosomes from body fluids of subjects affected by airway diseases. Furthermore, the most widespread techniques for exosome isolation and characterization are described. Further studies are needed to answer the unresolved questions about the functional link between exosomes and chronic respiratory diseases.
•Exosomes are nano-sized vesicles with an active role in chronic respiratory diseases.•Several exosome isolation and characterization techniques are available.•Exosomes from BALF, blood, NLF, sputum and EBC have been investigated in respiratory diseases.•Exosomes represent an innovative therapeutic and diagnostic tool. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ISSN: | 0753-3322 1950-6007 1950-6007 |
DOI: | 10.1016/j.biopha.2021.112270 |